Tumor-infiltrating platelets predict postoperative recurrence and survival in resectable pancreatic neuroendocrine tumor

doi:10.3748/wjg.v25.i41.6248

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 41

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5875)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

416

WORD

185

HTML

2774

Figures (1-2)

205

Tables (1-4)

172

Sum=3752

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

699

Download

1424

Sum=2123

Nov 7, 2019 (publication date) through Aug 25, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Nov 7, 2019; 25(41): 6248-6257
Published online Nov 7, 2019. doi: 10.3748/wjg.v25.i41.6248

Table 4 Multivariate Cox regression analyses of overall survival and recurrence-free survival with clinicopathologic characteristics in resectable pancreatic neuroendocrine tumor patients

Factor	OS			RFS
	HR	95%CI	P value	HR	95%CI	P value
Tumor grade, 1/2	5.882	1.848-18.719	0.003	3.283	1.345-8.016	0.009
TNM stage, 1, 2/3	5.136	1.062-24.842	0.042	2.366	1.219-4.591	0.011
CD42b expression, negative/positive	4.601	1.004-21.095	0.049	2.893	1.439-5.817	0.003

P < 0.05 was statistically significant. pNET: Pancreatic neuroendocrine tumor; CI: Confidence interval; HR: Hazard ratio; OS: Overall survival; RFS: Recurrence-free survival.

Citation: Xu SS, Xu HX, Wang WQ, Li S, Li H, Li TJ, Zhang WH, Liu L, Yu XJ. Tumor-infiltrating platelets predict postoperative recurrence and survival in resectable pancreatic neuroendocrine tumor. World J Gastroenterol 2019; 25(41): 6248-6257
URL: https://www.wjgnet.com/1007-9327/full/v25/i41/6248.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i41.6248